gonistes dérivés de l’ergot de seigle (« ergopeptines ») qui demandent une surveillance cardiaque annuelle par échocardiographie (risque de survenue de valvulopathies) : bromocriptine, lisuride;
gonistes derived from ergot of rye ("ergopeptines") that require annual cardiac monitoring by echocardiography (risk of valvular heart disease): bromocriptine, lisuride.
nists derived from ergot ("ergopeptines") that require annual cardiac monitoring by echocardiography (risk of developing valvulopathy): bromocriptine, lisuride;
Collaborators ergot derivatives ( "ergopeptines") which require monitoring annual heart by echocardiography (risk of occurrence of valve disease): bromocriptine, lisuride;